Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?

Autor: Vis, André N., van der Sluis, Tim M., Al-Itejawi, Hoda H.M., van Moorselaar, R. Jeroen A., Meuleman, Eric J.H.
Zdroj: In Urologic Oncology: Seminars and Original Investigations January 2015 33(1):7-15
Databáze: ScienceDirect